CanadaBis Capital, Inc. · TSXV:CANB.H
CanadaBis Capital — Investor Presentation (August 2023)
16 slides from CanadaBis Capital's investor presentation, August 2023
Slide 1: Investor Presentation August 2023
INVESTOR PRESENTATION AUGUST, 2023 A preliminary prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in each of the provinces of Canada, other than Quebec. A copy of the preliminary prospectus, an
Slide 2: Disclaimer
A copy of the preliminary short form prospectus (the “Prospectus”) has been filed with the securities regulatory authorities in each of the provinces of Canada, except Québec, but has not yet become final for the purpose of the sale of securities. A copy of the Prospectus in required to be delivered
Slide 3: Company & Brands
COMPANY & BRANDS PRODUCTION FACILITY / BRAND RETAIL LOCATION POWERED BY STIGMA GROW BRANDS CanadaBis Capital Inc. Investor Presentation 3
Slide 4: Financial Information - Q3 2023 Consolidated Results
FINANCIAL INFORMATION - Q3 2023 CONSOLIDATED RESULTS NET INCOME ADJUSTED EBITDA GROSS REVENUE $1.20 MM $1.53 MM $9.58 MM ($123,137) - Q3 2022 $468,536 - Q3 2022 $4.30 MM - Q3 2022 $37.7MM - YE 2020 GROSS MARGIN SHARE PRICE REVENUE GROWTH RATE $0.30 $2.70 MM 900% 122.66% $1.27 MM - Q3 2022 $0.03 - Q3
Slide 5: Annual and Quarterly Financial Review
ANNUAL AND QUARTERLY FINANCIAL REVIEW QUARTERLY FINANCIAL RESULTS ANNUAL FINANCIAL RESULTS REVENUE EBITDA REVENUE EBITDA 35,000,000 9.58 Mil 9.58 Mil 10,000,000 30 Mil 30,000,000 9,000,000 7.88 Mil 25,000,000 8,000,000 6.40 Mil 7,000,000 20,000,000 17.1 Mil 6,000,000 15,000,000 5,000,000 4,000,000 1
Slide 6: Positioning
POSITIONING CanadaBis Capital is a publicly traded Canadian cannabis company with 5 class leading brands in the Canadian recreational cannabis market. Stigma Grow (wholly owned subsidary) uses hydrocarbon concentrate (BHO) processing capabilities, uniquely equipped, experienced and licensed to pursu
Slide 7: Positioning Continued
POSITIONING CONTINUED Sales Performance by Province (% of total sales) KEY POINTS: >147K >1.7MM cases sold units sold • Concentrates are only just emerging in the Canadian market, and represent a small fraction of total sales, approximately 2%. (1) • Growth of market segment expected to reach levels
Slide 8: 2023 Production & Sell Through Overview
2023 PRODUCUTION & SELL THROUGH OVERVIEW CANADA CASE TOTAL: 147,187 CANADA UNIT TOTAL: 1,700,903 CANADA DRIED EQUIVALENCY TOTAL: 8,875,445 TOTAL MARKETS SOLD TO: 7 TOTAL SKUS LISTED: 356 CASE SALES BY PROVINCE 2022 2023 59,423 60,000 55,000 50,000 45,195 45,000 40,000 35,788 35,302 35,000 30,000 25,
Slide 9: Powered by Stigma Grow Brands
POWERED BY STIGMA GROW BRANDS At Stigma Grow we are consumers too! We commit our energy to producing cannabis products that we know our customers will get the most out of. While others are obsessed with profits, we are obsessed with customer satisfaction and as such take a “product first” approach t
Slide 10: Powered by Stigma Grow Brands Continued
POWERED BY STIGMA GROW BRANDS CONTINUED STIGMA GROW'S "CHAPTER 1" AND "BY STIGMA GROW" PRODUCTS ARE TYPICALLY FIRST-TO-MARKET PRODUCTS THAT WE BELIEVE DESERVE SHELF SPACE ACROSS CANADA. ONCE LISTED, THESE PRODUCTS ARECAREFULLY MONITORED FOR FIT UNDER ONE OF OUR PERMANENT BRANDS, OR AS AN OFFERING TO
Slide 11: Powered by Stigma Grow Brands Continued
POWERED BY STIGMA GROW BRANDS CONTINUED DAB BODS IS DESIGNED TO MAKE EVERY BODY COMFORTABLE WITH CONCENTRATES. FEATURING A LINEUP OF POTENT AND POPULAR PRODUCTS, LIKE SHATTER AND LIVE VAPES, AT SOME OF THE LOWEST PRICES AVAILABLE IN TODAY'S MARKET - DAB BODS IS FOCUSED ON EXPANDING THE CONCENTRATES
Slide 12: Powered by Stigma Grow Brands Continued
POWERED BY STIGMA GROW BRANDS CONTINUED HIGH PRIESTESS PRODUCTS HAVE BEEN UNIQUELY CREATED TO SPEAK TO WITH OUR INNER STRENGTHS AND WEAKNESSES. BUILT TO EXEMPLIFY THE POWER OUR ZODIAC SYMBOLS PLAY WITHIN OUR WORLDS, NOT ONLY THROUGH BRANDING, BUT CLEVERLY CREATING PRODUCTS TO FULFILL THE NEEDS OUR C
Slide 13: Powered by Stigma Grow Brands Continued
POWERED BY STIGMA GROW BRANDS CONTINUED OUR NGL LIVE-RESIN PRODUCTS FEATURE THE HIGH-TERPENE, FULL-SPECTRUM OFFERINGS (HTFSE) OF BOTH SATIVA AND INDICA-HEAVY STRAINS. WHILE OTHERS HAVE RECENTLY ENTERED THE MARKET - OUR POTENCY, PURITY AND PRICE HAVE MADE US THE COMFORTABLE MARKET LEADERS ACROSS CANA
Slide 14: Advantages: What Makes Us Unique
WHAT MAKES US UNIQUE STIGMA GROW PROMISE TRANSPARENCY AVAILABILITY AGILITY WE BELIEVE EVERYONE SHOULD FIND THE RIGHT- WE ARE A FAMILY-RUN COMPANY FOCUSED OUR RELATIVE SMALL-SIZE AND APPROACH TO FIT PRODUCTS FOR THEIR NEEDS. WITH THAT IN ON SLOW, STRATEGIC GROWTH THAT ALLOWS TEAMWORK ALLOWS QUICK ACT
Slide 15: Value Proposition
VALUE PROPOSITION Total Value (TV) Per Share Value Commentary Floor Value (As At April 30, 2023) (C$mm) (C$mm) Appraised Value of Cultivation Facility $21.70 $0.16 Debt -$8.40 -$0.06 Floor Value / Floor Value per Share $13.30 $0.10 Market Value Existing Operations (20x LQA Revenue) $62.50 $0.46 Base
Slide 16: Investor Relations
CAUTIONARY STATEMENTS FINANCIAL INFORMATION Prospective investors should rely only on the information contained in the Certain financial information included in this document is unaudited. There is preliminary short form prospectus dated June 1, 2021 (the “Prospectus). This a material risk that the
CanadaBis Capital — Investor Presentation (August 2023) on 6ix